FDA Clears Angiography Module for Spectralis Imaging Devices

The FDA cleared Spectralis’ optical coherence tomography angiography (OCTA) module for use with its new and existing diagnostic imaging devices.

OCTA is a non-invasive imaging technique that produces 3D visualization of perfused ocular vasculature.

The module allows physicians to gain better insights into ocular abnormalities.